Literature DB >> 28826180

Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.

Roberto Santangelo1, Giordano Cecchetti1, Maria Paola Bernasconi1, Rosalinda Cardamone1, Alessandra Barbieri1, Patrizia Pinto2, Gabriella Passerini3, Francesco Scomazzoni4, Giancarlo Comi1, Giuseppe Magnani1.   

Abstract

Co-existence of Alzheimer's disease (AD) in normal pressure hydrocephalus (NPH) is a frequent finding, thus a common pathophysiological basis between AD and NPH has been postulated. We measured CSF amyloid-β 42 (Aβ42), total tau (t-tau), and phosphorylated tau (p-tau) concentrations in a sample of 294 patients with different types of dementia and 32 subjects without dementia. We then compared scores on neuropsychological tests of NPH patients with pathological and normal CSF Aβ42 values. Aβ42 levels were significantly lower in NPH than in control patients, with no significant differences between AD and NPH. On the contrary, t-tau and p-tau levels were significantly lower in NPH than in AD, with no differences between NPH and controls. NPH patients with pathological Aβ42 levels did not perform worse than NPH patients with normal Aβ42 levels in any cognitive domains. Our data seem to support the hypothesis of amyloid accumulation in brains of NPH patients. Nevertheless, amyloid does not seem to play a pathogenetic role in the development of cognitive deficits in NPH.

Entities:  

Keywords:  Amyloid-β 42; cerebral amyloid burden; glymphatic system; normal pressure hydrocephalus; phosphorylated tau; tau protein

Mesh:

Substances:

Year:  2017        PMID: 28826180     DOI: 10.3233/JAD-170186

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

1.  CSF Biomarkers Predict Gait Outcomes in Idiopathic Normal Pressure Hydrocephalus.

Authors:  Jacqueline A Darrow; Alexandria Lewis; Seema Gulyani; Kristina Khingelova; Aruna Rao; Jiangxia Wang; Yifan Zhang; Mark Luciano; Sevil Yasar; Abhay Moghekar
Journal:  Neurol Clin Pract       Date:  2022-04

2.  P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status.

Authors:  Michelle R Campbell; Susan Ashrafzadeh-Kian; Ronald C Petersen; Michelle M Mielke; Jeremy A Syrjanen; Argonde C van Harten; Val J Lowe; Clifford R Jack; Joshua A Bornhorst; Alicia Algeciras-Schimnich
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-18

3.  Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.

Authors:  Madoka Nakajima; Shigeki Yamada; Masakazu Miyajima; Kazunari Ishii; Nagato Kuriyama; Hiroaki Kazui; Hideki Kanemoto; Takashi Suehiro; Kenji Yoshiyama; Masahiro Kameda; Yoshinaga Kajimoto; Mitsuhito Mase; Hisayuki Murai; Daisuke Kita; Teruo Kimura; Naoyuki Samejima; Takahiko Tokuda; Mitsunobu Kaijima; Chihiro Akiba; Kaito Kawamura; Masamichi Atsuchi; Yoshihumi Hirata; Mitsunori Matsumae; Makoto Sasaki; Fumio Yamashita; Shigeki Aoki; Ryusuke Irie; Hiroji Miyake; Takeo Kato; Etsuro Mori; Masatsune Ishikawa; Isao Date; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-01-15       Impact factor: 1.742

Review 4.  Nodding syndrome research, lessons learned from the NSETHIO project.

Authors:  D Geelhand de Merxem; J N Siewe Fodjo; S Menon; A Hotterbeekx; R Colebunders
Journal:  Glob Ment Health (Camb)       Date:  2019-10-18

5.  Neuroinflammation and Not Tauopathy Is a Predominant Pathological Signature of Nodding Syndrome.

Authors:  An Hotterbeekx; Martin Lammens; Richard Idro; Pamela R Akun; Robert Lukande; Geoffrey Akena; Avindra Nath; Joneé Taylor; Francis Olwa; Samir Kumar-Singh; Robert Colebunders
Journal:  J Neuropathol Exp Neurol       Date:  2019-11-01       Impact factor: 3.685

Review 6.  Onchocerca volvulus and epilepsy: A comprehensive review using the Bradford Hill criteria for causation.

Authors:  Robert Colebunders; Alfred K Njamnshi; Sonia Menon; Charles R Newton; An Hotterbeekx; Pierre-Marie Preux; Adrian Hopkins; Michel Vaillant; Joseph Nelson Siewe Fodjo
Journal:  PLoS Negl Trop Dis       Date:  2021-01-07

7.  Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.

Authors:  Michelle Kokkinou; Lucy C Beishon; Nadja Smailagic; Anna H Noel-Storr; Chris Hyde; Obioha Ukoumunne; Rosemary E Worrall; Anja Hayen; Meera Desai; Abhishekh Hulegar Ashok; Eleanor J Paul; Aikaterini Georgopoulou; Tiziana Casoli; Terry J Quinn; Craig W Ritchie
Journal:  Cochrane Database Syst Rev       Date:  2021-02-10

8.  Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus.

Authors:  Chihiro Akiba; Madoka Nakajima; Masakazu Miyajima; Ikuko Ogino; Yumiko Motoi; Kaito Kawamura; Satoshi Adachi; Akihide Kondo; Hidenori Sugano; Takahiko Tokuda; Kazuhiro Irie; Hajime Arai
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 9.  Current Updates on Idiopathic Normal Pressure Hydrocephalus.

Authors:  Boon Seng Liew; Kiyoshi Takagi; Yoko Kato; Shyam Duvuru; Sengottuvel Thanapal; Balamurugan Mangaleswaran
Journal:  Asian J Neurosurg       Date:  2019 Jul-Sep

10.  Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures.

Authors:  Nolbert Gumisiriza; Frank Mubiru; Joseph Nelson Siewe Fodjo; Martin Mbonye Kayitale; An Hotterbeekx; Richard Idro; Issa Makumbi; Tom Lakwo; Bernard Opar; Joice Kaducu; Joseph Francis Wamala; Robert Colebunders
Journal:  Infect Dis Poverty       Date:  2020-03-02       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.